The NIHR is investing £72 million to establish 14 new Commercial Research Delivery Centres (CRDCs) in England to enhance commercial clinical research speed and efficiency. These centres will support UK's status as a top research location, decentralize clinical trials to community settings, and ensure research inclusion for all eligible communities. Funded by the VPAG Investment Programme and NIHR, the initiative aims to boost UK's life sciences sector and economic growth.